CME Group recorded $1.392 billion of quarterly earnings on cash posted through its clearing system, an amount equal to 80.1% of the exchange operator’s reported revenue. But it also recorded $1.269 billion of related distributions to clearing firms. The net amount retained was about $122.7 million: 8.8% of the gross collateral earnings and 7.1% of company revenue. The scale of the gross line can therefore transform the apparent size of CME’s financial income unless the matched distribution is read at the same time.[1]
At 30 September, CME disclosed $139.1 billion held at the Federal Reserve Bank of Chicago as part of its cash performance-bond and guaranty-fund arrangements. That balance is not CME’s ordinary corporate cash and it is not customer revenue. It is clearing collateral placed to support obligations in the event of market moves and defaults. CME earns income while the cash is held and distributes most of it to clearing firms under its arrangements, leaving a smaller economic contribution than the gross earnings number suggests.[1]
The filing presents these items outside operating revenue, but their size is large enough to distort casual comparisons of total income. Someone reading only the $1.392 billion earnings line could conclude that collateral returns nearly rival the derivatives franchise. Someone reading only the $122.7 million net could miss the operational scale of the cash CME administers and the rate sensitivity embedded in clearing. Both views are incomplete. The investigative finding is the distribution mechanism: 91.2 cents of every disclosed dollar of collateral earnings was matched by a distribution expense.[1]
CME’s Q3 clearing-collateral economics
| Measure | Q3 2026 amount | Share or relationship | Correct interpretation |
|---|---|---|---|
| Collateral earnings | $1,391.7m | 80.1% of reported revenue | Gross income on clearing cash |
| Distributions to clearing firms | $1,269.0m | 91.2% of collateral earnings | Matched distribution expense |
| Net retained amount | $122.7m | 8.8% of collateral earnings | Analytical difference |
| Reported company revenue | $1,737.3m | Reference denominator | Operating revenue, not collateral balance |
The gross figure is a cash-flow scale measure, not a take rate
CME’s gross collateral earnings divided by the $139.1 billion Federal Reserve balance produces a quarterly ratio of about 1.00%, or roughly 4.00% when simply multiplied by four. That calculation is only a diagnostic. The earnings were generated over a quarter, whereas $139.1 billion is a single period-end balance. Daily average cash, changes in collateral composition, timing and yields are required for a true annualised return. The calculation demonstrates order of magnitude, not a contractual rate paid by the Federal Reserve or a forecast.[1]
A second calculation is more robust because it compares two income-statement figures from the same period. The $1.269 billion distribution divided by the $1.392 billion earnings line yields 91.2%. That ratio shows how much of the gross line was offset in the published quarter. It does not establish that each clearing member received the same percentage or that the residual is a fixed margin. Allocations can depend on balances, product rules, currencies and the terms governing collateral.[1]
The $122.7 million residual also should not be equated with free cash generated from collateral. Taxes, other non-operating items, liquidity needs and the timing of payments affect cash conversion. Nor does the calculation prove that CME bears no cost for operating the clearing system. Technology, risk management, default resources, staff and regulatory costs sit elsewhere in the accounts. The residual is a transparent difference between two disclosed lines, useful for scale analysis but not a complete profit-and-loss statement for clearing collateral.[1]
Diagnostic yield and distribution calculations
| Calculation | Result | Use | Limitation |
|---|---|---|---|
| $1,391.7m ÷ $139.1bn | About 1.00% for the quarter | Order-of-magnitude check | Ending balance is not quarterly average |
| Quarterly ratio × 4 | About 4.00% annualised | Rate sensitivity illustration | Not a realised annual yield |
| $1,269.0m ÷ $1,391.7m | 91.2% distributed | Matched-period ratio | Not member-by-member allocation |
| $122.7m ÷ $1,737.3m | 7.1% of revenue | Relative economic scale | Different accounting sections |
The nine-month comparison shows that the larger residual was not confined to one quarter. Gross collateral earnings rose 7.1% to US$4.1515 billion, distributions rose 5.7% to US$3.7839 billion and the analytical difference increased 23.9% to US$367.6 million. That residual represented 8.85% of gross earnings, up from 7.66% a year earlier. It remains a gross accounting spread before unallocated operating costs, capital charges and tax.[1]
Clearing collateral creates rate sensitivity outside the trading-fee narrative
CME is normally discussed through contract volume, revenue per contract, market data and clearing fees. The collateral lines expose another mechanism. When interest rates and clearing cash balances are high, gross earnings can become enormous even if most of the benefit is returned. When rates decline or collateral shifts, both earnings and distributions can fall together. A headline about falling collateral income would therefore not necessarily signal weakening trading demand, just as a rise would not necessarily mean CME captured the full benefit.[1]
For futures commission merchants and clearing members, the distribution can affect the economics of posting cash rather than securities. But the public filing does not identify the exact rate received by each intermediary or passed onward to end customers. A broker may retain, share or separately price collateral economics under its client agreements, subject to regulation and disclosure. CME’s group accounts cannot answer whether a particular futures customer received an appropriate return on margin cash.[1]
The legal character of the $139.1 billion also matters. Performance bonds and guaranty-fund contributions exist to protect the clearing system, not to finance CME’s ordinary acquisitions or shareholder distributions. The balance at the Federal Reserve should not be added to corporate liquidity or used to calculate net cash. Similarly, the gross earnings should not be combined with operating revenue and then assigned a conventional exchange margin without the distribution expense.[1]
Accounting and legal boundaries
| Item | Where it sits | What it supports | What it is not |
|---|---|---|---|
| Cash performance bonds and guaranty funds | Clearing arrangements | Participant obligations and default protection | Ordinary corporate cash |
| Collateral earnings | Non-operating income presentation | Return generated while cash is held | Trading-fee revenue |
| Clearing-firm distributions | Related expense | Amounts allocated back under arrangements | A discretionary dividend |
| Net analytical residual | Difference between disclosed lines | Scale of retained economics | Full clearing-segment profit |
Why the 91% figure matters for exchange comparisons
Exchange operators differ in whether and where they report interest on customer, clearing or settlement balances. A group that records gross interest and a matched distribution can look much larger than a peer reporting only a net spread. Cross-company rankings based on total income can therefore be meaningless unless analysts normalise the treatment. The same problem appears in bank sweeps, securities lending, client-money interest and payment processing: gross flows are not interchangeable with retained revenue.[1]
CME’s result also illustrates why “interest income” is not one homogeneous risk category. Corporate cash interest depends on treasury assets and capital allocation. Clearing-collateral earnings depend on member balances, margin requirements, approved depositories and central-bank rates. Net interest retained from customers or members depends on distribution policies. The counterparty, legal purpose and obligation to pass through the return determine the economic meaning, even when all three lines respond to interest rates.[1]
There is no evidence in this analysis that CME failed to distribute required amounts, misused collateral or misrepresented the accounts. The filing discloses both sides of the mechanism. The public-interest value is to prevent the gross earnings number from being mistaken for unrestricted profit and to show the scale of the clearing cash underlying it. A safe description is that CME generated $1.392 billion of gross collateral earnings and recognised $1.269 billion of related distributions in the quarter.[1]
The conclusion could be refined by a published quarterly average collateral balance, a currency and depository breakdown, or a formula explaining distribution by participant class. It would be falsified if the reported expense were shown to relate to a different earnings pool or period. On the current record, the same-quarter matching is direct and the difference is arithmetically reproducible. What remains unresolved is how the residual is generated across products and how much clearing members pass to their own clients.[1]
For regulators and market participants, the concentration of such a large balance at a central bank is also operationally significant. It reduces some commercial-bank credit exposure but places importance on payment access, settlement windows and the clearinghouse’s procedures. The filing does not identify an incident or weakness. It shows why collateral management is a core market-infrastructure function whose economics and resilience deserve analysis separately from contract volume.[1]
The collateral balance also creates a timing question for stress periods. If volatility raises margin requirements, cash posted at CME can rise at the same time that market participants face tighter liquidity elsewhere. Higher gross collateral earnings in such a quarter would not demonstrate that the system became less stressed; it could partly reflect the larger emergency liquidity buffer. Conversely, declining earnings might follow lower rates even if margin balances remain high. Revenue commentary should therefore separate rate, balance and stress effects.[1]
A clearing member’s own customer disclosure may introduce another layer. CME’s distribution to the member does not determine what the member credits to each client, because contracts, regulation and internal pricing intervene. Tracing that last mile would require broker agreements and account statements beyond CME’s filing.[1]
Evidence boundary for CME’s collateral finding
| Proposition | Status | Reason |
|---|---|---|
| 91.2% of Q3 collateral earnings had a matched distribution expense | Established calculation | Same-period filing lines |
| The gross line equalled 80.1% of reported revenue | Established comparison | $1,391.7m ÷ $1,737.3m |
| CME retained $122.7m before all other effects | Established arithmetic | Gross earnings less distributions |
| Every clearing customer received 91.2% | Not established | No participant-level allocation |
| The 4.00% diagnostic is a realised annual yield | Not established | Ending balance differs from average |
Sources & further reading
- Quarterly report for the three and nine months ended 30 September 2026 CME Group Inc. / US Securities and Exchange Commission · Accessed 8 Nov 2026